Key result
Supplementation of H2S attenuated hyperglycemia-induced elevations in reactive oxygen species and intrarenal renin-angiotensin system activation in cultured mesangial cells and diabetic rats.
Why the study?
Does H2S supplementation prevent hyperglycemia-induced intrarenal RAS activation and ROS generation in diabetic models?
Does H2S supplementation prevent hyperglycemia-induced intrarenal RAS activation and ROS generation in diabetic models?
Answers are grounded in this paper and cite their sources.
H2S supplementation attenuates hyperglycemia-induced intrarenal RAS activation by reducing ROS generation, suggesting a potential therapeutic mechanism for diabetic nephropathy.
Decrease in endogenous hydrogen sulfide (H2S) was reported to participate in the pathogenesis of diabetic nephropathy (DN). This study is aimed at exploring the relationship between the abnormalities in H2S metabolism, hyperglycemia-induced oxidative stress and the activation of intrarenal renin-angiotensin system (RAS). Cultured renal mesangial cells (MCs) and streptozotocin (STZ) induced diabetic rats were used for the studies. The expressions of angiotensinogen (AGT), angiotensin converting enzyme (ACE), angiotensin II (Ang II) type I receptor (AT1), transforming growth factor-β1 (TGF-β1) and collagen IV were measured by real time PCR and Western blot. Reactive oxygen species (ROS) production was assessed by fluorescent probe assays. Cell proliferation was analyzed by 5'-bromo-2'-deoxyuridine incorporation assay. Ang II concentration was measured by an enzyme immunoassay. AGT, ACE and AT1 receptor mRNA levels and Ang II concentration were increased in high glucose (HG) -treated MCs, the cell proliferation rate and the production of TGF-β1 and of collagen IV productions were also increased. The NADPH oxidase inhibitor diphenylenechloride iodonium (DPI) was able to reverse the HG-induced RAS activation and the changes in cell proliferation and collagen synthesis. Supplementation of H2S attenuated HG-induced elevations in ROS and RAS activation. Blockade on H2S biosynthesis from cystathione-γ-lyase (CSE) by DL-propargylglycine (PPG) resulted in effects similar to that of HG treatment. In STZ-induced diabetic rats, the changes in RAS were also reversed by H2S supplementation without affecting blood glucose concentration. These data suggested that the decrease in H2S under hyperglycemic condition leads to an imbalance between oxidative and reductive species. The increased oxidative species results in intrarenal RAS activation, which, in turn, contributes to the pathogenesis of renal dysfunction.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2013) studied Diabetic nephropathy (n=24). NaHS (H2S donor) vs. Vehicle / High glucose alone was evaluated on Intrarenal RAS activation (AGT, ACE, AT1 receptor expression) and ROS generation. Supplementation of H2S attenuated hyperglycemia-induced elevations in reactive oxygen species and intrarenal renin-angiotensin system activation in cultured mesangial cells and diabetic rats.
Synapse has enriched 10 related papers. Consider them for comparative context: